D.E. Shaw & Co’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2019
Q2
Sell
-84,433
Closed -$88K 2868
2019
Q1
$88K Sell
84,433
-71,816
-46% -$74.9K ﹤0.01% 2457
2018
Q4
$117K Sell
156,249
-171,920
-52% -$129K ﹤0.01% 2446
2018
Q3
$696K Buy
328,169
+1,900
+0.6% +$4.03K ﹤0.01% 1963
2018
Q2
$754K Buy
326,269
+19,506
+6% +$45.1K ﹤0.01% 1998
2018
Q1
$976K Buy
306,763
+25,833
+9% +$82.2K ﹤0.01% 1825
2017
Q4
$1.15M Buy
280,930
+122,914
+78% +$504K ﹤0.01% 1774
2017
Q3
$714K Buy
158,016
+102,549
+185% +$463K ﹤0.01% 1935
2017
Q2
$185K Buy
55,467
+33,623
+154% +$112K ﹤0.01% 2273
2017
Q1
$201K Buy
+21,844
New +$201K ﹤0.01% 2282
2015
Q4
Sell
-18,112
Closed -$300K 2921
2015
Q3
$300K Buy
18,112
+8,557
+90% +$142K ﹤0.01% 2230
2015
Q2
$215K Buy
+9,555
New +$215K ﹤0.01% 2452
2013
Q4
Sell
-47,733
Closed -$731K 2840
2013
Q3
$731K Buy
+47,733
New +$731K ﹤0.01% 1721